Skip to main content

Belumosudil Dosage

Medically reviewed by Drugs.com. Last updated on Jun 21, 2022.

Applies to the following strengths: 200 mg

Usual Adult Dose for Graft Versus Host Disease

200 mg orally once a day until progression of chronic GVHD that requires new systemic therapy

Use: For the treatment of adults with chronic graft-versus-host disease (chronic GVHD) after failure of at least 2 prior lines of systemic therapy

Usual Pediatric Dose for Graft Versus Host Disease

200 mg orally once a day until progression of chronic GVHD that requires new systemic therapy

Use: For the treatment of pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least 2 prior lines of systemic therapy

Renal Dose Adjustments

Data not available. For patients with preexisting severe renal impairment, consider the risks and potential benefits before initiating therapy with this drug.

Liver Dose Adjustments

Data not available. For patients with preexisting severe hepatic impairment, consider the risks and potential benefits before initiating therapy with this drug.

Dose Adjustments

Dose Modifications for Adverse Reactions:
HEPATOTOXICITY:

OTHER ADVERSE REACTIONS:

Precautions

CONTRAINDICATIONS: None

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Monitoring:

Patient advise:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.